IREN just posted its biggest single-day gain in months — a 30.5% jump to $38.26 on July 30 — yet the short base has grown heavier still, setting up one of the more charged positioning conflicts in the digital asset infrastructure space right now.
The lending market tells an extreme story. Short interest reached 35.3% of the free float by Thursday's close — up from 33.2% when last week's note was filed, and nearly double the level from a month ago. That's roughly 100 million shares held short. Availability has not recovered; it closed at just 1.97%, barely off the 52-week low of 1.97% touched the day before. For context, that means fewer than two shares remain available for every hundred already borrowed. Every share in the lending pool that can be lent has been lent, with the borrow market running at full saturation for more than two weeks consecutively. Despite this, the cost to borrow remains remarkably cheap at 1.07% — up only 5% on the week. That paradox has persisted across multiple notes: the entrenched short book borrowed early at favourable rates, while new entrants face a structurally locked market. The options market has turned more guarded alongside this. The put/call ratio of 1.07 is running above its 20-day average of 1.00 and sits near the 52-week high of 1.08, confirming that derivatives traders are leaning defensive even as the stock rockets higher.
That 30.5% single-day move is where the tension crystallises. The entire peer group surged in tandem: CIFR gained 28%, HUT rose 23%, CORZ added 20%, and CLSK climbed 21%. The sector-wide bid on July 30 was genuine, not IREN-specific. Yet on the week, IREN is still down 5.7% — less than KEEL (down 15.8%) or CIFR (down 12.3%), but underperforming RIOT and CLSK. Short sellers who were in place before the daily move absorbed a painful session, but the weekly net is still in their favour.
The Street remains constructively positioned but well above the current price. HC Wainwright raised its target to $90 on July 22, matching Macquarie's standing Outperform at $90. Canaccord holds at $79 and B. Riley leads the group at $96. The consensus is a split between Hold and Outperform — no firm has cut to a Sell despite the stock trading at $38, roughly 55–60% below the analyst cluster of $79–$99. That gap is either deep value or a sign that targets haven't caught down to reality. The ORTEX short score of 68.8 ranks IREN in the bottom 6th percentile on short positioning — meaning the short-seller conviction around this name is heavier than 94% of comparable stocks. Analyst recommendation divergence scores in the 93rd percentile, capturing exactly that split: bulls are bullish, bears are very short. EPS momentum is deteriorating sharply, ranked in the 1st percentile on both 30- and 90-day windows, which is the data point bears are anchoring to. The bull case rests on $3.4B contracted ARR and the APAC expansion; the bear case points to execution risk on ramp timelines, dilution risk, and the gap between contracted revenue and cash generation.
The ORTEX short score has drifted fractionally lower over recent sessions, from 68.83 on July 28 to 68.83 on July 30 — essentially flat for the week. What has changed is the arithmetic: with 100 million shares short and availability near zero, any sustained move higher compresses the exit options for the short book. The next earnings event is scheduled for August 28. The last two prints produced muted initial reactions — a -4% day-one move in May followed by a near-flat open — but both resolved in opposite directions over the subsequent week.
The August 28 print becomes the next hard test: whether IREN's contracted ARR narrative translates into a revenue ramp that justifies analyst targets, or whether execution shortfalls give the record short book its confirmation.
See the live data behind this article on ORTEX.
Open IREN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
